Table 3.
Clinical parameters, urinary podocyte markers, and classification of histologic stage in patients with membranous nephropathy
| Patient | Sex | Age, yr | eGFR, ml/min per 1.73 m2 |
Systolic BP, mm Hg |
Diastolic BP, mm Hg |
Total Protein, g/dl |
Albumin, g/dl |
Urinary Protein Creatinine Ratio, g/gCr |
log PodCR | log PCX | Histologic Stage |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 71 | 67.6 | 142 | 75 | 4.7 | 2.0 | 0.31 | 4.88 | 6.70 | III |
| 2 | F | 78 | 46.1 | 137 | 63 | 6.5 | 3.4 | 0.18 | 3.08 | 4.08 | II |
| 3 | M | 83 | 11.8 | 152 | 82 | 5.0 | 1.7 | 7.30 | 4.75 | 3.99 | II |
| 4 | M | 68 | 41.3 | 124 | 80 | 8.6 | 1.9 | 8.11 | 5.48 | 5.26 | I |
| 5 | F | 78 | 74.5 | 118 | 72 | 6.1 | 3.0 | 1.44 | 4.26 | 5.58 | I |
| 6 | F | 35 | 95.6 | 72 | 39 | 4.7 | 1.5 | 4.24 | 1.54 | 4.97 | I |
| 7 | M | 59 | 96.4 | 126 | 87 | 6.7 | 3.1 | 2.40 | 0.69 | 5.14 | III |
| 8 | F | 71 | 35.2 | 120 | 68 | 4.4 | 1.7 | 8.12 | 3.69 | 5.67 | III |
| 9 | F | 33 | 62.0 | 117 | 75 | 5.7 | 3.5 | 0.84 | −0.31 | 4.84 | III |
| 10 | M | 76 | 73.5 | 131 | 81 | 6.0 | 2.5 | 1.27 | 3.57 | 5.01 | III |
| 11 | F | 71 | 106.2 | 121 | 70 | 4.7 | 2.3 | 2.28 | 6.25 | 6.41 | III |
| 12 | M | 63 | 65.5 | 111 | 82 | 4.6 | 1.8 | 2.05 | 2.13 | 6.30 | II |
| 13 | F | 66 | 94.0 | 128 | 68 | 5.4 | 2.4 | 4.29 | 4.09 | 6.07 | I |
| 14 | M | 42 | 70.2 | 129 | 68 | 4.4 | 1.8 | 1.91 | 3.42 | 6.19 | II |
| 15 | F | 74 | 67.9 | 130 | 55 | 4.5 | 1.9 | 6.49 | 3.92 | 7.08 | II |
Pt, patient; log PodCR, log u-sed pod mRNA; log PCX, log u-sup PCX protein; F, female; M, male.